Central Nervous System Infections Rare but Devastating Following Heart Transplantation

Article

Central nervous system infections develop infrequently following heart transplants but are a significant predictor of death, according to an article posted online today that will appear in the December 2007 print issue of Archives of Neurology.

In the past 10 years, approximately 24,000 Americans have undergone heart transplantation, according to background information in the article. Improvements in surgical techniques and immunosuppressive medications have resulted in increased survival rates for transplant recipients.

Diederik van de Beek, MD, PhD, and colleagues at the Mayo Clinic College of Medicine, Rochester, studied 315 consecutive patients who underwent heart transplants there from January 1988 through June 2006. Data were gathered from the clinic databases, electronic and paper medical records, laboratory records and cranial imaging tests.

Eight patients (3 percent) developed central nervous system infections, all within four years after transplantation. The most common symptoms were confusion or headache (88 percent), often without the classic signs of fever and neck stiffness. Three of the eight patients died (38 percent), and two (25 percent) survived with mild complications.

Three patients developed cryptococcal meningitis, two had progressive multifocal leukoencephalopathy, two had varicella-zoster virus encephalitis, and one had Aspergillus fumigatus infection. Varicella-zoster virus encephalitis has not been previously reported in heart transplant recipients, to our knowledge, but has been described in patients after bone marrow transplantation or in patients with HIV infection, the authors write. Whether varicella-zoster virus encephalitis is emerging in other transplant populations should be a subject of further research.

Examining the cerebrospinal fluid did not necessarily help determine the cause of central nervous system infections, though protein levels were usually elevated in infected patients. Nevertheless, appropriate management and rapid diagnosis can be achieved by taking a careful history and with physical examination, neuroimaging and diagnostic microbiological techniques, the authors write. Because the mortality and morbidity rates are high, aggressive diagnosis and intervention are warranted in heart transplant recipients with suspected central nervous system infection.

Reference: Arch Neurol. 2007;64(12):(doi:10.1001/archneur.64.12.noc70065)).

Source: American Medical Association

Related Videos
Medical investigators going over data. (AdobeStock 589197902 by Wasan)
CDC logo is seen on a laptop. (Adobe Stock 428450603 by monticellllo)
Association for the Health Care Environment (Logo used with permission)
Ambassador Deborah Birx, , speaks with Infection Control Today about masks in schools and the newest variant.
mRNA technology  (Adobe Stock 485886181 by kaptn)
Ambassador Deborah Birx, MD
Woman lying in hospital bed (Adobe Stock, unknown)
Photo of a model operating room. (Photo courtesy of Indigo-Clean and Kenall Manufacturing)
GIANTmicrobes at the 2023 APIC Annual Conference and Exhibition.  (Photo by the author)
Related Content